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ABSTRACT
Purpose: The purpose of the article is to present 8 new cases of metastatic tumors occurring in the jawbones, their clinical 
features , diagnostic workup and management.
Patients and methods: The records of  8 patients with metastatic jaw lesions were reviewd. Demographic data, presenting 
symptoms, primary tumor site, radiographic findings, bone scintigraphy , histopathology and clinical management were 
analyzed.   
Results: The  patients , ranged in age from 44 to 80 years, with a mean of  64.5 years. The  primary malignant sites were: 
the lung , the breast , the  rectum, the thyroid, the uterus and the parotid gland . The mandible was the site of oral invol-
vement in seven cases and the maxilla in one.  There was no gender difference with respect to the oral site affected. The 
clinical jaw  presentations were: exophytic soft tissue  mass, paresthesia of the lower lip and a periapical lesion The provided 
treatment  protocols were: chemotherapy , radiotherapy and chemotherapy, surgery and chemotherapy and supportive care 
only.  In one case the jaw lesion was the first indication of an unknown malignancy at a distant primary site.
Conclusions: Metastatic jaw lesions are uncommon. Paresthesia of the lower lip and the chin is a sinister sign for patients 
with a metastatic jaw lesion. In view of these cases it can be said that meticulous work-up of of jaw lesions suspected 
of being metastatic, may be life saving or extend the patient’s survival period.
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INTRODUCTION
Metastatic tumors to  the oral region are uncommon,  com-
prising only 1%-3% of all malignant oral neoplasms. These 
tumors, however, are of great clinical significance, as their 
appearance may be the first indication of an undiscovered 
malignancy at a distant primary site, or the first evidence 
of dissemination of a known tumor from its primary site. 
Metastatic lesions may occur in the oral soft tissues, in the 
jawbones or in both osseous and soft tissue. The common 
primary sources of tumors metastatic to the oral region are 
the breast, lung and kidney. The lung is the most common 
source of metastases to the oral soft tissues, whereas the 
breast is the most common source for metastatic tumors 
to the jawbones. In the jawbones the mandible is the most 
common location for metastases, with the molar area being 
the most frequently involved site (1-4 ).
The diagnosis of a metastatic lesion in the oral region is 
challenging , both to the clinician and to the pathologist. 
The clinician must recognize the possibility that a lesion may 
represent a metastasis, and the pathologist must determin 
the site of tumor origin.   
The purpose of this article is to present eight  new cases of 
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metastatic tumor (MT) of the jaws , their clinical features 
and management.  
PATIENTS AND METHODS
During the eight year period  (1996-2004) eight patients 
with the diagnosis of  MT to the jawbones were treated 
at the Department of Oral and Maxillofacial Surgery at 
the Soroka University Medical Center. We conducted a 
retrospective review of their charts, with attention to pa-
tient demographics, presenting symptoms, history of other 
tumors, radiographic and clinical findings, histopathology 
and treatment. The findings are presented, along with a 
discussion of MT to the jawbones.
RESULTS
The clinical fearures of  the eight cases of  MT to the jaw-
bones are presented in Table 1. Three of the patients were 
males and five were females. Ages ranged from  44 to 80 
years, with a mean of  64.5 years . 
The  primary malignant sites  were:  the lung (2 cases), the 
breast (2 cases), the  rectum, the thyroid, the uterus and the 
parotid gland (1 case each). The mandible was the main site 
of oral involvement in seven cases and the maxilla in one 
case ( Figure 1) .
In the mandible five  cases were on the right side whereas 
two cases were on the left side. There was no gender di-
fference with respect to the oral site affected. The clinical 
presentations  were :  exophytic soft tissue  mass in five cases, 
paresthesia of the lower lip in two cases and a periapical 
lesion in one case. The jaw metastasis were diagnosed an 
average of  28.5 months (range 0 - 48 months) after initial 
tumor diagnosis at the primary site. The provided treatment 
protocols were: chemotherapy (in 3 cases), radiotherapy and 
chemotherapy (in 2 cases) , surgery and chemotherapy (in 1 
case) and supportive care only (2 cases) ( Table 1). Treatment  
protocols were determined by the hospital tumor board 
or in consultation with a senior oncologist, based on the 
systemic condition of the patient at the time of diagnosis 
of the metastatic lesion. In one patient the jaw lesion was 
the presenting feature  and a solitary MT, whereas in seven 
patient the jaw lesions  were  part of  a more  extensive 
metastatic process.  Patients were followed for an average 
of  19.5 months (range 1- 91 months), which represents 
the time period between the discovery of the jaw MT and 
their death . The cause of death was widespead metastatic 













F 47 Ductal carcinoma of breast 48






F 67 Non small cell carcinoma of lung 33 Exophytic  mass 
Supportive
care only 4
M 67 Adenocarcinoma of rectum 11/21 Exophytic mass Chemo 14 
M 71 Non small cell carcinoma of lung 42/43 Periapical lesion Chemo 1 
F 44 Ductal carcinoma of breast 46
Paresthesia of lower 





48 Local  mass Supportivecare only 2









46 Local mass Radiationand Chemo 3
Table 1. Clinical features of metastatic tumors to the jaws.
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DISCUSSION
The oral cavity, and the jawbones are occasionally the site 
for MT from primary malignant tumors elsewhrere in the 
body. It is reported that MT account for only 1%-3% of all 
malignant neoplasms presenting in the oral region. However, 
as the jaws are not routinely examined at autopsy, the true 
frequency of MT in the jaws may posssibly be higher (1). 
The typical tumors that metastasize to the jaws in order 
of decreasing frequency are : breast, lung, kidney, colon, 
prostate and thyroid. MT to the jaw bones is a long term 
process. The time difference between the initial diagnosis 
of the malignancy at the primary site and the diagnosis of 
the jaw MT , in our cases was an average of  28.5 months, 
which correspnds to the time frame of discovery of general 
bone metastasis, namely, 1-5 years (5).  
As reported by others (1,4,6) , MT to the jaws more often 
occur in the mandible than in the maxilla , and most often in 
posterior mandible. This site preference exists despite the 
fact that the mandible and maxilla share a common blood 
supply, the maxillary artery. 
Paresthesia of  the lower lip and the chin was found in 
Fig. 1. A 67 years old male with adenocarcinoma  of the rectum and metastatic tumor of the maxilla 
(a)  Bulging of the upper lip can be noted. 
(b) Exophytic mass of the anterior maxilla.
(c) Axial CT of the maxilla demonstrates bone destruction in the anterior maxilla.
(d) High magnification photomicrograph. Malignant glands are seen between bone spicules. 
Fig. 1. (a) Fig. 1. (b)
Fig. 1. (c)
Fig. 1. (d)
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two of our patients. As reported by others, this should be 
considered an ominous sign for metastatic lesions to the 
mandible, as this signifies deep invasion of the tumor into 
the bone and involvement of the inferior dental or mental 
nerves. When seen in a patient with a known malignancy, 
mental nerve neuropathy or the “numb chin syndrome”, in 
the absensce of other causes, should be considered to be due 
to mandibular metastses until proven otherwise (7-9).  
The radiological changes in the jaw bones, found in our se-
ries,  depend mainly on the mineral loss in the area of tumor, 
as compared to the adjacent bone. Although most of the 
metastatic lesions to the jaw bones are osteolytic, some of 
the lesions, particularly prostatic metastates, are more likely 
to be osteoblastic (10,11). In some of the reported autopsy 
cases, metastses were found on histologic examination of  in 
the mandible despite the fact that no radiological changes 
were detectable (12). Thus, lack of radiographic changes 
does not exclude the possible presence of a small metastatic 
lesion in the jaw bone. Unlike the oral soft tissues , where 
a potentially metastaic lesion can be easily recognized, the 
presence of an early focus of tumor metastasis in the jawbo-
ne may be overlooked. Bone scintigraphy  was performed in 
all our patients, and in ageement with others (13,14) it was 
found to be an important tool for the detection of relatively 
small lesions.
The criteria by which one can consider a malignant jaw 
lesion to be a MT include:  
(a) histologic verification – namely finding that the primary 
tumor and the jaw lesion are identical from a histologic 
standpoint, including special staining and  other studies 
such as EM. 
(b) the fact that the MT is not found in a site typical to 
primary oral tumors.
(c) the fact that the possibility of direct extension to the 
jawbones from a primary oral tumor can be exluded (1,3). 
(d) genetic analysis - namely,  the identical cytogenetic 
findings in both the primary  tumor and in the metastatic jaw 
lesion, can be an important contribution  to the histopathologic 
diagnosis of the lesion, being a metastatsis (15).
The exact mechanism of tumor metastasis from distant sites 
to the jawbones is not fully understood. However, autop-
sy records indicate that tumors tend to be site-specific in 
their patterns of metastases. For many tumors the nearest 
anatomic site encountered will be the most common site 
for metastatic-colony formation. Other tumors are more 
“selective” and by-pass nearby proximal organs and selec-
tively colonize in a specific distal organ (16). The primary 
tumors that metastatize  to the oral region and the jawbones 
probably belong to the group of  “more selective” tumors. 
The common routes of  metastases by distant tumors to 
the oral region and/or the jawbones are via the lymphatic 
channels or by hematogenous spread.      
COMMENT
We have presented eight cases of metastatic tumors to the 
jawbones. The  presentation of a malignant lesion in the oro-
facial region may be the first indication  of  the existence of 
an unknown malignancy at a distant primary site. Lack of 
radiographic changes in the jawbones in the presence of su-
ggestive symptoms does not absolutely exclude the possible 
presence of a MT. The presence of altered sensation  in the 
area of the lower jaw and lip/chin region in a patient with 
a known non-head and neck malignancy should alert the 
clinician to the possibility of metastatic malignant disease 
and the appropriate investigation should be conducted. 
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